Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. [electronic resource]
Producer: 20060914Description: 1561-8 p. digitalISSN:- 0003-9926
- Adolescent
- Adult
- Aged
- Benzazepines -- adverse effects
- Bupropion -- therapeutic use
- Dopamine Uptake Inhibitors -- therapeutic use
- Double-Blind Method
- Female
- Follow-Up Studies
- Health Status
- Humans
- Male
- Middle Aged
- Nicotinic Agonists -- adverse effects
- Nicotinic Antagonists -- adverse effects
- Quinoxalines -- adverse effects
- Smoking Cessation -- methods
- Tobacco Use Disorder -- drug therapy
- Treatment Outcome
- Varenicline
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.